Paediatric Consumer Health in France

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

The outbreak of COVID-19 is set to benefit sales of paediatric consumer health products, with the landscape moving from value growth of 4% in 2019, to 5% value growth predicted for 2020.

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Paediatric cough, cold and allergy remedies are expected to have the worst performance in 2020, recording a double-digit value decline. These products have already been struggling across the forecast period, due to a mistrust around cold medication, with consumers looking for more natural alternatives for their children.

Bayer Sante Familiale SAS leads the landscape, with Merck Médication Familiale SAS also benefiting from the current climate

Bayer Sante Familiale SAS is set to continue leading the landscape in 2020, with its popular and trusted nappy (diaper) rash cream. Nappy (diaper) rash treatments is expected to see positive results from the outbreak of COVID-19.

RECOVERY AND OPPORTUNITIES

Following an uplift in sales due to COVID-19, sales are set to decline from 2021; however, growth will remain steady and positive across the forecast period

Following an uplift in growth in 2020, due to the outbreak of COVID-19 and stockpiling, paediatric consumer health is set to return to lower growth levels in 2021, when it will record 3% value growth. Growth is then set to remain steady and positive across the rest of the forecast period, driven by paediatric vitamins and dietary supplements and paediatric acetaminophen.

The landscape will be increasingly challenged by natural alternatives, as OTC options continue to cause concern

As with the adult landscape, over the counter paediatric medication is set to struggle across the forecast period, with numerous warnings and precautions surrounding certain OTC drugs - such as those to treat coughs, for example - contributing to the distrust French consumers have towards medications.

Innovation remains limited; however, opportunities exist for paediatric vitamins and dietary supplements

Over the forecast period, paediatric vitamins and dietary supplements is expected to continue leading value sales, with the growing health and wellness trend supporting growth. In addition, many consumers are keen to ensure they are doing all they can to support their child’s growth and development, with parents looking to add vitamin and dietary supplements to their children’s daily diets.